In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Royalty Pharma plc

http://www.royaltypharma.com

Latest From Royalty Pharma plc

Medtechs Must Reflect On China Localization Policies As VBP Expands

China continues to roll out volume-based procurement for medical devices and pharma products and companies should plan their strategies accordingly, advises EY Parthenon’s Hua Su.

China Pricing Strategies

China VBP, Localization And Other Strategies - How Far And Which Way?

Could health sector players encounter issues similar to those facing Tesla in China, a country which virtually saved the electric vehicle maker but where it is now facing challenges? Are there any lessons to be learned from a success story under China's volume-based procurement scheme? A partner at EY looks at these and other issues in an interview with Scrip.

China Commercial

China Localization – VBP Sees Global Medtechs Ponder Stay Or Exit

It is the time of year when global healthcare industry CEOs descend on China's capital to discuss strategies. A change of mood is evident among medtechs and pharmas.

China Policy

End Game: Adrenomed Targets Global Reach For Sepsis Candidate

German biotech Adrenomed has proof-of-concept data showing its sepsis drug can cut mortality by 67%. Now, it needs money to move the candidate into Phase IIb/III trials.

Market Intelligence Infectious Diseases
See All

Company Information

  • Industry
  • Miscellaneous
  • Other Names / Subsidiaries
    • Cypress Bioscience, Inc. (Cellatope Corporation
    • Proprius Pharmaceuticals, Inc.)
    • Ramius LLC
    • Royalty Pharma AG
UsernamePublicRestriction

Register